We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$3.6B
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.96% |
| 3 | Technology | 16.37% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
3M
MMM
$94.3B
| $24.6M | 0.05% |
226,928
+66,422
| +41% | +$8.03M |
|
377
Nabors Industries
NBR
$1.21B
| $24.5M | 0.05% |
183,290
+89,313
| +95% | +$14M |
|
378
HEICO Corp
HEI
$51.4B
| $24.4M | 0.05% |
186,229
+181,332
| +3,703% | +$25.6M |
|
379
Thor Industries
THO
$4.14B
| $24.3M | 0.05% |
+325,767
| New | +$25.3M |
|
380
FIVE9
FIVN
$2.54B
| $24.3M | 0.05% |
266,412
-114,976
| -30% | -$11.6M |
|
381
Prologis
PLD
$133B
| $24.2M | 0.05% |
+206,029
| New | +$28.5M |
|
|
LTHM
382
DELISTED
Livent Corporation
LTHM
| $24.2M | 0.05% |
+1,065,907
| New | +$27.4M |
|
383
Allstate
ALL
$67.5B
| $24.2M | 0.05% |
190,790
+183,978
| +2,701% | +$24.1M |
|
|
MPT
384
Medical Properties Trust
MPT
$2.81B
| $24.2M | 0.05% |
1,582,825
-661,002
| -29% | -$11.9M |
|
385
Kimberly-Clark
KMB
$36.5B
| $24.1M | 0.05% |
178,644
-132,217
| -43% | -$17.4M |
|
386
Alnylam Pharmaceuticals
ALNY
$29.3B
| $24.1M | 0.05% |
+165,292
| New | +$23.4M |
|
387
Denali Therapeutics
DNLI
$3.97B
| $24.1M | 0.05% |
817,650
+664,795
| +435% | +$17.4M |
|
|
LCA
388
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
| $23.9M | 0.05% |
2,443,554
| – | – |
|
|
JNPR
389
DELISTED
Juniper Networks
JNPR
| $23.8M | 0.05% |
834,451
+85,335
| +11% | +$2.69M |
|
|
ACC
390
DELISTED
American Campus Communities, Inc.
ACC
| $23.7M | 0.05% |
+368,316
| New | +$23.3M |
|
|
FSNB
391
DELISTED
Fusion Acquisition Corp. II
FSNB
| $23.7M | 0.05% |
2,416,639
| – | – |
|
|
SMAR
392
DELISTED
Smartsheet Inc.
SMAR
| $23.7M | 0.05% |
754,105
+88,545
| +13% | +$3.67M |
|
|
MIT
393
DELISTED
Mason Industrial Technology, Inc.
MIT
| $23.7M | 0.05% |
2,423,479
| – | – |
|
394
PUT
VanEck Semiconductor ETF
SMH
$73.2B
| $23.7M | 0.05% |
232,200
+201,200
| +649% | +$23.4M |
|
|
RBCP
395
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $23.6M | 0.05% |
250,000
| – | – |
|
|
GRMN
396
Garmin
GRMN
$60B
| $23.6M | 0.05% |
240,120
-275,258
| -53% | -$29M |
|
|
HAAC
397
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $23.5M | 0.05% |
2,374,119
| – | – |
|
398
British American Tobacco
BTI
$128B
| $23.4M | 0.05% |
544,721
+436,854
| +405% | +$18.7M |
|
|
EDR
399
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $23.4M | 0.05% |
1,136,076
+1,034,934
| +1,023% | +$23.5M |
|
400
Digital Realty Trust
DLR
$71.7B
| $23.3M | 0.05% |
+179,281
| New | +$24.8M |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.